US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Osteopore Limited (OSX) 銘柄情報

Osteopore Limited (OSX)

0.006

0.00

(0.00%)

終了 6月10日 3:00PM

Osteopore Limited (OSX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.006

( - )

買値

0.005

売値

0.006

出来高

13,948,272

0.0055 日の範囲 0.006

0.005 52 週間の範囲 0.029

時価総額

前日終値

0.006

始値

0.006

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 4,469,866

発行済株式数

626,358,066

配当利回り

PER

-0.3

1 株当たり利益 (EPS)

-0.02

歳入

3.06M

純利益

-3.72M

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company comm... Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.osteopore.com

本社

Singapore, Singapore

設立

2026

Osteopore Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker OSX. The last closing price for Osteopore was AUD0.01. Over the last year, Osteopore shares have traded in a share price range of AUD 0.005 to AUD 0.029.

Osteopore currently has 626,358,066 shares in issue. The market capitalisation of Osteopore is AUD3.76 million. Osteopore has a price to earnings ratio (PE ratio) of -0.30.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.006	0.0065	0.0055	1466733	0.006	DE
4	-0.001	-14.2857142857	0.007	0.01	0.0055	6886334	0.00681207	DE
12	-0.001	-14.2857142857	0.007	0.01	0.005	4182428	0.00664524	DE
26	-0.002	-25	0.008	0.029	0.005	7966242	0.01210753	DE
52	-0.007	-53.8461538462	0.013	0.029	0.005	5156090	0.01200619	DE
156	-0.08	-93.023255814	0.086	0.755	0.005	2540443	0.02492343	DE
260	-0.439	-98.6516853933	0.445	0.755	0.005	1546406	0.03007787	DE

OSX - Frequently Asked Questions (FAQ)

What is the current Osteopore Limited share price?

The current share price of Osteopore Limited is AUD 0.006

How many Osteopore Limited shares are in issue?

Osteopore Limited has 626,358,066 shares in issue

What is the market cap of Osteopore Limited?

The market capitalisation of Osteopore Limited is AUD 3.76M

What is the 1 year trading range for Osteopore Limited share price?

Osteopore Limited has traded in the range of AUD 0.005 to AUD 0.029 during the past year

What is the PE ratio of Osteopore Limited?

The price to earnings ratio of Osteopore Limited is -0.3

What is the cash to sales ratio of Osteopore Limited?

The cash to sales ratio of Osteopore Limited is 1.23

What is the registered address of Osteopore Limited?

The registered address for Osteopore Limited is 2 Tukang Innovation Grove #09-06/07, Singapore, 618305

What is the Osteopore Limited website address?

The website address for Osteopore Limited is www.osteopore.com

Which industry sector does Osteopore Limited operate in?

Osteopore Limited operates in the Medical Equipment & Supplies sector

callmepadrino

callmepadrino 5分前

Can somebody explain why this is going up?

Doc logic

Doc logic 5分前

learningcurve2020,

The crossover wasn’t done for the trial, if was done for the patients AND that was the right thing to do as crossover patients obviously benefitted more than even the general population with regard to OS comparative benefit not absolute benefit. Best wishes.

ElectricOgre36

ElectricOgre36 5分前

https://youtu.be/fm0-S2HBxUE I am holdign my shares.

europa7

europa7 5分前

Clarity Act News: Senate Kills Ethics Amendment, Leaving Officials Free to Profit from Crypto
"...Clarity Act Ethics Amendment Defeated in Senate Vote..."
June 9, 2026
https://www.coinspeaker.com/senate-kills-ethics-amendment-clarity-act/

"...In Clarity Act news t

ElectricOgre36

ElectricOgre36 5分前

https://youtu.be/fm0-S2HBxUE

WebSlinger

WebSlinger 6分前

It looks like a whale is consistently dumping shares over the days, weeks, and months.

I see the same pattern almost every day. Mostly selling throughout the day, and then in the last 1/2 hour or so, they buy enough shares to raise the price back up to paint the tape at the close.

ElectricOgre36

ElectricOgre36 6分前

I am holding on to my shares. https://youtu.be/fm0-S2HBxUE

VVVVVV

Number 1, this is regarding the Device case and not the Telcom case. Two separate cases! No one knows if the judge will decide separately or not.

Secondly, I heard it’s about a 8-9 page response to something the defendants added. Probably wouldn’t delay much, if any.

al19

Hey Don, thanks for bringing it to our attention so quickly as the news hasnt hit to wires yet. It is a true loss and may he rest in piece.
I do apoogize for the misunderstanding.

Trooperstocks

Trooperstocks 7分前

$MAJI NexTel intends to utilize proceeds from its LMMY shares to fund the transaction. Consequently, there will be no share dilution to existing $MAJI stockholders. The final closing of the transaction is anticipated to take place within 60 to 75 days, subject to the delivery of audited financial st

TightCoil

TightCoil 7分前

Everything you say will be used against you,
and you have no right to an attorney or priest

Trooperstocks

Trooperstocks 7分前

$MAJI NexTel intends to utilize proceeds from its LMMY shares to fund the transaction. Consequently, there will be no share dilution to existing $MAJI stockholders. The final closing of the transaction is anticipated to take place within 60 to 75 days, subject to the delivery of audited financial st

ollik78

ollik78 8分前

MTEN Offering @2

murrayhill

murrayhill 8分前

He can; &
a nice little guitar he inherited from Tommy Comeau's estate, cap.

pinhigh

pinhigh 8分前

Doesn't bother me in the the least that flippers can't make any money off Biel at this time! When a stock starts showing staying power like Biel has...the flippers will look elsewhere.

WebSlinger

WebSlinger 8分前

>

You should get a new AI.

Mr. C

Your perpetual whining probably helps lower the PPS

manfromjax

manfromjax 9分前

To put it into pictures...

https://investorshub.advfn.com/uimage/uploads/2026/6/9/ebchidrain.jpg

via CoPilot

thundersteel

thundersteel 9分前

Thanks, I see them now... I'll check these out today.

Ty, gg

Porch Honkey

Porch Honkey 10分前

Give it up, you not getting my shares, gl.

Monroe1

Monroe1 10分前

4. The 36-month follow-up CONFIRMED the benefit keeps going — something almost no MASH drug has ever shown.
At 36 months:

• New varices incidence: 12.4% at 2 mg/kg vs 23.4% placebo
The advantage persisted for 3 years.
This is extremely rare in cirrhosis.

Gus1212

Gus1212 11分前

Very Powerful Statement
So, for anyone grinding out "contract posts" on IHUB for someone else’s short fund, they should look into the SEC Whistleblower Program. It pays 10% to 30% of recovered sanctions. The first one to turn over the internal coordination logs gets the deal. The others might

brazen22

brazen22 12分前

At this point your posts read more like they are written by a cheerleader than by someone addressing the issues.

So I thought I’d offer you a real cheer to use. Feel free to use this royalty free, online or offline.

Two, four, six, eight,
Every delay means someth

Porch Honkey

Porch Honkey 12分前

I feel a big change coming on, gl.

holt69

holt69 12分前

They've got a heavy administrative cost. Too many people on the payroll bringing no value to the company. This was a little bit of a problem with RXMD, and it's MUCH worse for NXPL.

A blatant middle finger to the fiduciary duty responsibility by the entire Board.

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。